177 related articles for article (PubMed ID: 23238661)
21. Pharmacological management of cystic fibrosis related diabetes.
Moheet A; Moran A
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
[TBL] [Abstract][Full Text] [Related]
23. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
Sherwood JS; Castellanos LE; O'Connor MY; Balliro CA; Hillard MA; Gaston SG; Bartholomew R; Greaux E; Sabean A; Zheng H; Marchetti P; Uluer A; Sawicki GS; Neuringer I; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
Diabetes Care; 2024 Jan; 47(1):101-108. PubMed ID: 37874987
[TBL] [Abstract][Full Text] [Related]
24. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
Rafii M; Chapman K; Stewart C; Kelly E; Hanna A; Wilson DC; Tullis E; Pencharz PB
Am J Clin Nutr; 2005 Feb; 81(2):421-6. PubMed ID: 15699230
[TBL] [Abstract][Full Text] [Related]
25. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
26. Long-term benefits in lung function and nutritional status of strict metabolic control of cystic fibrosis-related diabetes.
Martín-Frías M; Máiz L; Carcavilla A; Barrio R
Arch Bronconeumol; 2011 Oct; 47(10):531-4. PubMed ID: 21798655
[TBL] [Abstract][Full Text] [Related]
27. Incidence and risk factors of paediatric cystic fibrosis-related diabetes.
Perrem L; Stanojevic S; Solomon M; Carpenter S; Ratjen F
J Cyst Fibros; 2019 Nov; 18(6):874-878. PubMed ID: 31072797
[TBL] [Abstract][Full Text] [Related]
28. Managing diabetes in cystic fibrosis.
Laguna TA; Nathan BM; Moran A
Diabetes Obes Metab; 2010 Oct; 12(10):858-64. PubMed ID: 20920037
[TBL] [Abstract][Full Text] [Related]
29. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
Moheet A; Moran A
Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis related diabetes: Medical management.
Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
[TBL] [Abstract][Full Text] [Related]
31. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis-related diabetes before lung transplantation is associated with lower survival but does not affect long-term renal function.
Mainbourg S; Philit F; Touzet S; Nove-Josserand R; Durupt S; Sénéchal A; Occelli P; Poupon-Bourdy S; Maury JM; Tronc F; Mornex JF; Durieu I; Reynaud Q
Pediatr Pulmonol; 2019 Jul; 54(7):977-983. PubMed ID: 30854801
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
[TBL] [Abstract][Full Text] [Related]
34. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
[TBL] [Abstract][Full Text] [Related]
35. Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence.
Ararat E; Sonawalla A; Berlinski A; Tas E
Pediatr Pulmonol; 2021 Oct; 56(10):3217-3222. PubMed ID: 34245493
[TBL] [Abstract][Full Text] [Related]
36. Adherence to clinical care guidelines for cystic fibrosis-related diabetes in 659 German/Austrian patients.
Scheuing N; Berger G; Bergis D; Gohlke B; Konrad K; Laubner K; Lilienthal E; Moser C; Schütz-Fuhrmann I; Thon A; Holl RW;
J Cyst Fibros; 2014 Dec; 13(6):730-6. PubMed ID: 24917115
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of cystic fibrosis-related diabetes.
Marshall BC; Butler SM; Stoddard M; Moran AM; Liou TG; Morgan WJ
J Pediatr; 2005 May; 146(5):681-7. PubMed ID: 15870674
[TBL] [Abstract][Full Text] [Related]
38. Cystic Fibrosis-Related Diabetes in Poland.
Rachel M; Biesiadecki M; Galiniak S
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409752
[TBL] [Abstract][Full Text] [Related]
39. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
40. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
